Assenagon Asset Management
PFE icon

Assenagon Asset Management’s Pfizer PFE Stock Holding History

Assenagon Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287M Buy
11,902,374
+5,829,204
+96% +$152M 0.36% 48
2026
Q1 		$171M Buy
6,073,170
+4,009,711
+194% +$107M 0.26% 65
2025
Q4 		$51.4M Sell
2,063,459
-6,625,644
-76% -$167M 0.07% 208
2025
Q3 		$221M Buy
8,689,103
+3,722,531
+75% +$91.9M 0.3% 61
2025
Q2 		$120M Sell
4,966,572
-5,079,768
-51% -$118M 0.18% 114
2025
Q1 		$255M Buy
10,046,340
+7,581,030
+308% +$198M 0.42% 39
2024
Q4 		$65.4M Sell
2,465,310
-2,709,185
-52% -$73.5M 0.11% 164
2024
Q3 		$150M Buy
5,174,495
+407,967
+9% +$11.9M 0.28% 59
2024
Q2 		$133M Sell
4,766,528
-1,205,066
-20% -$33.2M 0.3% 67
2024
Q1 		$166M Sell
5,971,594
-401,898
-6% -$11.2M 0.39% 45
2023
Q4 		$183M Buy
6,373,492
+2,191,326
+52% +$66.2M 0.49% 33
2023
Q3 		$139M Buy
4,182,166
+1,107,971
+36% +$39.2M 0.43% 39
2023
Q2 		$113M Sell
3,074,195
-3,799,004
-55% -$148M 0.39% 43
2023
Q1 		$280M Buy
6,873,199
+3,689,877
+116% +$159M 1% 17
2022
Q4 		$163M Sell
3,183,322
-9,217,842
-74% -$442M 0.59% 33
2022
Q3 		$543M Buy
12,401,164
+10,429,412
+529% +$507M 2.08% 6
2022
Q2 		$103M Sell
1,971,752
-2,628,162
-57% -$134M 0.38% 46
2022
Q1 		$238M Buy
4,599,914
+834,467
+22% +$43.3M 0.66% 27
2021
Q4 		$222M Buy
3,765,447
+6,775
+0.2% +$336K 0.64% 29
2021
Q3 		$162M Buy
3,758,672
+470,790
+14% +$20.9M 0.52% 41
2021
Q2 		$129M Buy
+3,287,882
New +$128M 0.44% 40
2021
Q1 		– Sell
-933,123
Closed -$34.3M – 1283
2020
Q4 		$34.3M Buy
933,123
+126,486
+16% +$4.64M 0.15% 123
2020
Q3 		$28.1M Buy
806,637
+799,136
+10,654% +$28M 0.16% 100
2020
Q2 		$233K Buy
+7,501
New +$255K ﹤0.01% 1051
2020
Q1 		– Sell
-86,908
Closed -$3.23M – 947
2019
Q4 		$3.23M Buy
86,908
+79,003
+999% +$2.81M 0.02% 312
2019
Q3 		$269K Sell
7,905
-3,457,189
-100% -$126M ﹤0.01% 759
2019
Q2 		$142M Buy
3,465,094
+3,444,014
+16,338% +$137M 1.07% 25
2019
Q1 		$849K Sell
21,080
-1,803,740
-99% -$72.2M 0.01% 722
2018
Q4 		$75.6M Sell
1,824,820
-473,533
-21% -$19.7M 0.86% 23
2018
Q3 		$96.1M Buy
2,298,353
+1,980,615
+623% +$76.2M 0.95% 16
2018
Q2 		$10.9M Sell
317,738
-349,167
-52% -$11.9M 0.13% 171
2018
Q1 		$22.5M Buy
666,905
+632,501
+1,838% +$21.7M 0.29% 94
2017
Q4 		$1.18M Sell
34,404
-1,966,909
-98% -$67.1M 0.01% 511
2017
Q3 		$67.8M Buy
+2,001,313
New +$64.3M 0.63% 45
2017
Q1 		– Sell
-218,486
Closed -$6.73M – 301
2016
Q4 		$6.73M Buy
+218,486
New +$6.67M 0.13% 122

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Assenagon Asset Management's PFE Position: Q2 2026 in Review

Assenagon Asset Management increased its Pfizer (PFE) stake by 96% in Q2 2026, buying an estimated $152M and bringing the position to 11,902,374 shares worth $287M. The position accounts for 0.36% of the portfolio, ranked #48.

Assenagon Asset Management first reported a position in PFE in Q4 2016 and has held it in 35 quarters since. The position peaked at $543M in Q3 2022. 1,149 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Assenagon Asset Management held 11,902,374 shares of Pfizer worth $287M as of Q2 2026.
  • Assenagon Asset Management bought 5,829,204 Pfizer shares in Q2 2026, an estimated $152M.
  • Pfizer made up 0.36% of Assenagon Asset Management's portfolio in Q2 2026, its #48 holding.
  • Assenagon Asset Management first reported a position in Pfizer in Q4 2016 and has held it in 35 quarters since.
  • Assenagon Asset Management's Pfizer position peaked at $543M in Q3 2022.
  • 1,149 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.